Ascendis Health Statistics

Total Valuation

Ascendis Health has a market cap or net worth of ZAR 538.15 million. The enterprise value is 647.22 million.

Market Cap	538.15M
Enterprise Value	647.22M

Important Dates

The next estimated earnings date is Wednesday, June 25, 2025.

Earnings Date	Jun 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Ascendis Health has 625.75 million shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class	n/a
Shares Outstanding	625.75M
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.60%
Owned by Institutions (%)	0.09%
Float	108.87M

Valuation Ratios

The trailing PE ratio is 29.78.

PE Ratio	29.78
Forward PE	n/a
PS Ratio	0.73
PB Ratio	0.82
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	44.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.91, with an EV/FCF ratio of -82.32.

EV / Earnings	35.79
EV / Sales	0.88
EV / EBITDA	25.91
EV / EBIT	n/a
EV / FCF	-82.32

Financial Position

The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.17.

Current Ratio	0.62
Quick Ratio	0.05
Debt / Equity	0.17
Debt / EBITDA	4.53
Debt / FCF	-14.41
Interest Coverage	-0.13

Financial Efficiency

Return on equity (ROE) is 2.78% and return on invested capital (ROIC) is -0.14%.

Return on Equity (ROE)	2.78%
Return on Assets (ROA)	-0.11%
Return on Invested Capital (ROIC)	-0.14%
Return on Capital Employed (ROCE)	-0.26%
Revenue Per Employee	52.46M
Profits Per Employee	1.29M
Employee Count	14
Asset Turnover	0.76
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.70% in the last 52 weeks. The beta is 0.37, so Ascendis Health's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+3.70%
50-Day Moving Average	82.90
200-Day Moving Average	77.66
Relative Strength Index (RSI)	48.05
Average Volume (20 Days)	895,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ascendis Health had revenue of ZAR 734.49 million and earned 18.08 million in profits. Earnings per share was 0.03.

Revenue	734.49M
Gross Profit	283.26M
Operating Income	-1.68M
Pretax Income	19.40M
Net Income	18.08M
EBITDA	11.50M
EBIT	-1.68M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 4.18 million in cash and 113.26 million in debt, giving a net cash position of -109.08 million or -0.17 per share.

Cash & Cash Equivalents	4.18M
Total Debt	113.26M
Net Cash	-109.08M
Net Cash Per Share	-0.17
Equity (Book Value)	658.68M
Book Value Per Share	1.05
Working Capital	-61.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.20 million and capital expenditures -20.07 million, giving a free cash flow of -7.86 million.

Operating Cash Flow	12.20M
Capital Expenditures	-20.07M
Free Cash Flow	-7.86M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 38.57%, with operating and profit margins of -0.23% and 2.46%.

Gross Margin	38.57%
Operating Margin	-0.23%
Pretax Margin	2.64%
Profit Margin	2.46%
EBITDA Margin	1.57%
EBIT Margin	-0.23%
FCF Margin	n/a

Dividends & Yields

Ascendis Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.11%
Shareholder Yield	0.11%
Earnings Yield	3.36%
FCF Yield	-1.46%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ascendis Health has an Altman Z-Score of -6.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.78
Piotroski F-Score	n/a